Merus reports promising early data for petosemtamab in colorectal cancer
PositiveFinancial Markets

Merus has announced promising early data for its drug petosemtamab in the treatment of colorectal cancer. This development is significant as it offers hope for patients battling this challenging disease, potentially leading to more effective treatment options and improved outcomes.
— Curated by the World Pulse Now AI Editorial System